Insider · CIK 0001306267

Unkart Edward W

Reports to the SEC for 3 companies · FRAMINGHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001306267

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-10-01	KalVista Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-10-03	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-09-26	KalVista Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2022-10-13	KalVista Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-09-30	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-10-01	KalVista Pharmaceuticals, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2019-10-02	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	$11.21	+$78.5K	7,000
2018-10-03	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2017-09-27	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2017-03-23	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2015-08-03	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+29K sh	—	—	29,000
2009-06-17	VNUS MEDICAL TECHNOLOGIES INCU Disposition from Tender	Director	UDisposition from Tender	−6,000 sh	$29.00	−$174K	5,000
2009-06-17	VNUS MEDICAL TECHNOLOGIES INCD Disposition to Issuer	Director	DDisposition to Issuer	−1,250 sh	$29.00	−$36.3K	0
2009-06-17	VNUS MEDICAL TECHNOLOGIES INCStock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,000 sh	—	—	0
2009-06-17	VNUS MEDICAL TECHNOLOGIES INCStock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,000 sh	—	—	0
2009-06-17	VNUS MEDICAL TECHNOLOGIES INCStock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2009-06-17	VNUS MEDICAL TECHNOLOGIES INCStock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2009-06-17	VNUS MEDICAL TECHNOLOGIES INCStock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2009-05-23	VNUS MEDICAL TECHNOLOGIES INCM Exercise/Conversion	Director	MExercise/Conversion	+750 sh	—	—	11,000
2009-05-23	VNUS MEDICAL TECHNOLOGIES INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−750 sh	—	—	0
2009-05-20	VNUS MEDICAL TECHNOLOGIES INCA Award	Director	AAward	+5,000 sh	—	—	10,250
2009-02-23	VNUS MEDICAL TECHNOLOGIES INCM Exercise/Conversion	Director	MExercise/Conversion	+750 sh	—	—	5,250
2009-02-23	VNUS MEDICAL TECHNOLOGIES INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−750 sh	—	—	750
2008-08-23	VNUS MEDICAL TECHNOLOGIES INCM Exercise/Conversion	Director	MExercise/Conversion	+750 sh	—	—	3,750
2008-08-23	VNUS MEDICAL TECHNOLOGIES INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−750 sh	—	—	2,250
2008-06-18	XTENT INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2008-05-18	VNUS MEDICAL TECHNOLOGIES INCM Exercise/Conversion	Director	MExercise/Conversion	+750 sh	—	—	3,000
2008-05-18	VNUS MEDICAL TECHNOLOGIES INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−750 sh	—	—	0
2007-06-20	XTENT INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2007-02-06	XTENT INCC Conversion	Director	CConversion	+8,333 sh	—	—	8,333
2007-02-06	XTENT INCSeries A Convertible Preferred StockC Conversion	Director	CConversion	−8,333 sh	—	—	0
2005-05-17	VNUS MEDICAL TECHNOLOGIES INCStock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Jun 114
Unkart Edward W0001306267-26-000002
SEC(opens sec.gov)
Oct 24
Unkart Edward W0001306267-25-000004
SEC(opens sec.gov)
Oct 44
Unkart Edward W0001415889-24-024748
SEC(opens sec.gov)
Sep 284
Unkart Edward W0001209191-23-050757
SEC(opens sec.gov)
Oct 174
Unkart Edward W0001209191-22-053878
SEC(opens sec.gov)
Oct 14
Unkart Edward W0001209191-21-058488
SEC(opens sec.gov)
Oct 24
Unkart Edward W0001209191-20-053399
SEC(opens sec.gov)
Oct 34
Unkart Edward W0001567619-19-019233
SEC(opens sec.gov)
Oct 54
Unkart Edward W0001567619-18-003784
SEC(opens sec.gov)
Sep 294
Unkart Edward W0001140361-17-037017
SEC(opens sec.gov)
Mar 274
KalVista Pharmaceuticals, Inc.0001140361-17-013502
SEC(opens sec.gov)

Companies

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702